Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Pharmaceuticals
Elliott Takes Big Stake in Drugmaker Catalent
The activist is pushing for a shake-up of the contract drug manufacturer’s board. Source link
FDA Approves First RSV Drug to Protect All Infants
While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
Eli Lilly to Acquire Versanis Bio, Maker of Obesity Treatment
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional payments if certain milestones are
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. Source link
Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer
Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products. Source link
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days Source link
FDA Approves First Over-the-Counter Birth-Control Pill
The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S. Source link
60 Degrees Pharmaceuticals Prices 1.42M Unit IPO at $5.30/unit By Investing.com
© Reuters. 60 Degrees Pharmaceuticals (SXTP) Prices 1.42M Unit IPO at $5.30/unit WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services,
Investor Group Takes Aim at Antibiotics, Demanding Changes From Fast-Food Companies
Concern over the rise of drug-resistant superbugs is spreading beyond hospital wards and health clinics to the world’s major financial centers. Source link